Hexamethylenetetramine from India: Final Affirmative Determination of Sales at Less Than Fair Value and Final Affirmative Determination of Critical Circumstances, in Part

<NOTICE> DEPARTMENT OF COMMERCE <SUBAGY>International Trade Administration</SUBAGY> <DEPDOC>[A-533-932]</DEPDOC> <SUBJECT>Hexamethylenetetramine from India: Final Affirmative Determination of Sales at Less Than Fair Value and Final Affirmative Determination of Critical Circumstances, in Part</SUBJECT> <HD SOURCE="HED">AGENCY:</HD> Enforcement and Compliance, International Trade Administration, Department of Commerce. <SUM> <HD SOURCE="HED">SUMMARY:</HD> The U.S. Department of Commerce (Commerce) determines that hexamethylenetetramine (hexamine) from India is being, or is likely to be, sold in the United States at less than fair value (LTFV). The period of investigation is July 1, 2023, through June 30, 2024. </SUM> <DATES> <HD SOURCE="HED">DATES:</HD> Applicable September 23, 2025. </DATES> <FURINF> <HD SOURCE="HED">FOR FURTHER INFORMATION CONTACT:</HD> Dylan Hill, AD/CVD Operations, Office IV, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-1197. </FURINF> <SUPLINF> <HD SOURCE="HED">SUPPLEMENTARY INFORMATION:</HD> <HD SOURCE="HD1">Background</HD> On May 6, 2025, Commerce published in the <E T="04">Federal Register</E> its preliminary affirmative determination in the LTFV investigation of hexamine from India, <SU>1</SU> <FTREF/> in which we also postponed the final determination until September 18, 2025, and invited interested parties to comment on the <E T="03">Preliminary Determination.</E> On August 20, 2025, we issued a post-preliminary analysis memorandum in which we made certain changes to Commerce's differential pricing analysis. <SU>2</SU> <FTREF/> <FTNT> <SU>1</SU>   <E T="03">See Hexamethylenetetramine from India: Preliminary Affirmative Determination of Sales at Less Than Fair Value, Postponement of Final Determination, and Extension of Provisional Measures,</E> 90 FR 19178 (May 6, 2025) ( <E T="03">Preliminary Determination</E> ), and accompanying Preliminary Decision Memorandum. </FTNT> <FTNT> <SU>2</SU>   <E T="03">See</E> Memorandum, “Post-Preliminary Analysis for the Affirmative Determination in the Less-Than-Fair-Value Investigation of Hexamethylenetetramine from India,” dated August 20, 2025. </FTNT> A summary of the events that occurred since Commerce published the <E T="03">Preliminary Determination,</E> as well as a full discussion of the issues raised by parties for this final determination, may be found in the Issues and Decision Memorandum. <SU>3</SU> <FTREF/> The Issues and Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance's Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at <E T="03">https://access.trade.gov.</E> In addition, a complete version of the Issues and Decision Memorandum can be accessed directly at <E T="03">https://access.trade.gov/public/FRNoticesListLayout.aspx.</E> <FTNT> <SU>3</SU>   <E T="03">See</E> Memorandum, “Issues and Decision Memorandum for the Final Affirmative Determination of Sales at Less Than Fair Value in the Investigation of Hexamethylenetetramine from India,” dated concurrently with, and hereby adopted by, this notice (Issues and Decision Memorandum). </FTNT> <HD SOURCE="HD1">Scope of the Investigation</HD> The product covered by this investigation is hexamine from India. For a complete description of the scope of this investigation, <E T="03">see</E> Appendix I. <HD SOURCE="HD1">Scope Comments</HD> We received no comments from interested parties on the scope of the investigation as it appeared in the <E T="03">Preliminary Determination.</E> Therefore, we made no changes to the scope of the investigation from that published in the <E T="03">Preliminary Determination</E> for the final determination. <HD SOURCE="HD1">Verification</HD> As provided in section 782(i) of the Tariff Act of 1930, as amended (the Act), in June 2025, we conducted a verification of the sales and cost information submitted by the sole mandatory respondent, Kanoria Chemicals and Industries Limited (Kanoria), for use in the final determination. <SU>4</SU> <FTREF/> We used standard verification procedures, including an examination of relevant sales and accounting records, and original source documents provided by Kanoria. <FTNT> <SU>4</SU>   <E T="03">See</E> Memorandum, “Verification of the Kanoria Chemicals and Industries Limited in the Less-Than-Fair-Value Investigation of Hexamethylenetetramine from India,” dated August 20, 2025. </FTNT> <HD SOURCE="HD1">Analysis of Comments Received</HD> All issues raised in the case and rebuttal brief submitted by interested parties in this investigation are addressed in the Issues and Decision Memorandum. A list of the issues addressed in the Issues and Decision Memorandum is attached to this notice as Appendix II. <HD SOURCE="HD1">Use of Adverse Facts Available</HD> In the <E T="03">Preliminary Determination,</E> we based the estimated weighted-average dumping margin of the companies that did not timely respond to the quantity and value questionnaire ( <E T="03">i.e.,</E> Horizon Chemicals, Micro Labs Limited, Shreenathji Rasayan Private Limited, and Rajsha Chemicals Pvt. Ltd.) on adverse facts available (AFA). No parties commented on that decision. As explained in the Issues and Decision Memorandum, we have continued to base the estimated weighted-average dumping margin of these companies on AFA, pursuant to sections 776(a) and (b) of the Act. Final Affirmative Determination of Critical Circumstances, in Part On August 27, 2025, Bakelite LLC (the petitioner) alleged that critical circumstances exist with respect to U.S. imports of hexamine from India. <SU>5</SU> <FTREF/> We determine that critical circumstances do not exist for Kanoria, and all other companies not individually examined, except for the companies to which we applied AFA ( <E T="03">i.e.,</E> Horizon Chemicals, Micro Labs Limited, Shreenathji Rasayan Private Limited, and Rajsha Chemicals Pvt. Ltd.), pursuant to section 735(a)(3) of the Act and 19 CFR 351.206. For a discussion of Commerce's critical circumstances analysis, <E T="03">see</E> the Issues and Decision Memorandum. <FTNT> <SU>5</SU>   <E T="03">See</E> Petitioner's Letter, “Critical Circumstances Allegation,” dated August 27, 2025. </FTNT> <HD SOURCE="HD1">Changes Since the Preliminary Determination</HD> We made certain changes to the <E T="03">Preliminary Determination.</E> For a discussion of these changes, <E T="03">see</E> the Issues and Decision Memorandum. <SU>6</SU> <FTREF/> <FTNT> <SU>6</SU>   <E T="03">See also</E> Memorandum, “Analysis for the Final Determination,” dated concurrently with this notice. </FTNT> <HD SOURCE="HD1">All-Others Rate</HD> Section 735(c)(5)(A) of the Act provides that Commerce shall determine an estimated all-others rate for all exporters and producers not individually examined. This rate shall be an amount equal to the weighted average of the estimated weighted-average dumping margins established for exporters and producers individually investigated, excluding any zero and <E T="03">de minimis</E> margins, and any margins determined entirely under section 776 of the Act. Commerce calculated an individual estimated weighted-average dumping margin for Kanoria, the only individually examined exporter/producer in this investigation, that is not zero, <E T="03">de minimis,</E> or based entirely on facts otherwise available. Therefore, we assigned the estimated weighted-average dumping margin that we calculated for Kanoria to all other producers and exporters, pursuant to section 735(c)(5)(A) of the Act. <HD SOURCE="HD1">Final Determination</HD> Commerce determines that the following estimated weighted-average dumping margins exist for the period, July 1, 2023, through June 30, 2024: <GPOTABLE COLS="3" OPTS="L2,tp0,i1" CDEF="s50,12,12"> <TTITLE> </TTITLE> <CHED H="1">Exporter/producer</CHED> <ENT I="01">Kanoria Chemicals and Industries Limited</ENT> <ENT>5.11</ENT> <ENT> <SU>7</SU>  3.12 </ENT> </ROW> <ROW> <ENT I="01">Horizon Chemicals</ENT> <ENT>* 105.76</ENT> <ENT>103.77</ENT> </ROW> <ROW> <ENT I="01">Micro Labs Limited</ENT> <ENT>* 105.76</ENT> <ENT>103.77</ENT> </ROW> <ROW> <ENT I="01">Shreenathji Rasayan Private Limited</ENT> <ENT>* 105.76</ENT> <ENT>103.77</ENT> </ROW> <ROW> <ENT I="01">Rajsha Chemicals Pvt. Ltd</ENT> <ENT>* 105.76</ENT> <ENT>103.77</ENT> </ROW> <ROW> <ENT I="01">All Others</ENT> <ENT>5.11</ENT> <ENT>3.12</ENT> </ROW> <TNOTE>* Rate based on facts available with adverse inferences.</TNOTE> </GPOTABLE> <HD SOURCE="HD1">  Adjusted for export subsidies of 1.99 percent (comprised of 1.19 percent for the duty drawback program, and 0.80 percent for the remissions of duties and taxes on export products program) for Kanoria and All Others. <E T="03">See</E> unpublished <E T="04">Federal Register</E> notice, “Hexamethylenetetramine from India: Final Affirmative Countervailing Duty Determination and Final Affirmative Critical Circumstances Determination, In Part,” and accompanying Issues and Decision Memorandum, dated September 18, 2025. </FTNT> Commerce intends to disclose the calculations performed in connection with this final determination to parties to the proceeding within five days of any public announcement or, if there is no public announcement, within five days of the date of publication of this notice in the <E T="04">Federal Register</E> , in accordance with 19 CFR 351.224(b). <HD SOURCE="HD1">Continuation of Suspension of Liquidation</HD> In accordance with section 735(c)(1)(B) of the Act, for Kanoria and the companies to which the All-Others d ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Preview showing 10k of 19k characters. Full document text is stored and available for version comparison. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━